Savaria (TSE:SIS) Price Target Raised to C$39.00 at Desjardins

Savaria (TSE:SIS) had its price objective hoisted by investment analysts at Desjardins from C$36.00 to C$39.00 in a report released on Friday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Desjardins’ price target suggests a potential upside of 28.71% from the company’s previous close.

A number of other research analysts also recently issued reports on SIS. TD Securities upgraded Savaria to a “strong-buy” rating in a research note on Friday, July 24th. Raymond James Financial boosted their price target on shares of Savaria from C$32.00 to C$33.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. ATB Cormark Capital Markets increased their price target on shares of Savaria from C$32.00 to C$35.00 and gave the company an “outperform” rating in a research report on Wednesday, April 15th. TD raised their price objective on shares of Savaria from C$31.00 to C$35.00 and gave the stock a “buy” rating in a report on Wednesday, April 15th. Finally, National Bank Financial lifted their price objective on shares of Savaria from C$30.50 to C$37.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the stock. Based on data from MarketBeat, Savaria presently has an average rating of “Buy” and an average price target of C$34.33.

Savaria Stock Performance

Shares of Savaria stock traded down C$0.54 during mid-day trading on Friday, hitting C$30.30. 213,749 shares of the stock were exchanged, compared to its average volume of 179,088. Savaria has a 12 month low of C$20.10 and a 12 month high of C$31.95. The company has a 50-day simple moving average of C$29.73 and a 200 day simple moving average of C$27.82. The company has a market capitalization of C$2.18 billion, a P/E ratio of 27.55, a P/E/G ratio of 42.72 and a beta of 1.04. The company has a debt-to-equity ratio of 31.42, a quick ratio of 0.91 and a current ratio of 1.71.

Savaria (TSE:SIS) last released its earnings results on Wednesday, August 5th. The company reported C$0.35 earnings per share (EPS) for the quarter. The company had revenue of C$245.78 million during the quarter. Savaria had a return on equity of 12.41% and a net margin of 8.50%. Sell-side analysts anticipate that Savaria will post 1.2048518 earnings per share for the current fiscal year.

Insider Transactions at Savaria

In other news, Director Peter Allen Drutz sold 9,736 shares of the company’s stock in a transaction on Saturday, June 6th. The stock was sold at an average price of C$29.00, for a total transaction of C$282,344.00. Following the transaction, the director owned 95,251 shares of the company’s stock, valued at C$2,762,279. This represents a 9.27% decrease in their position. Also, Director Marcel Bourassa sold 7,500 shares of the stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of C$29.53, for a total value of C$221,475.00. Following the transaction, the director owned 225,431 shares of the company’s stock, valued at C$6,656,977.43. The trade was a 3.22% decrease in their position. In the last three months, insiders have sold 62,500 shares of company stock valued at $1,761,124. Corporate insiders own 17.45% of the company’s stock.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.